Home › Funds › EMERALD ADVISERS, LLC › CORT

EMERALD ADVISERS, LLC position in CORT

CORCEPT THERAPEUTICS INC · Health Care

EMERALD ADVISERS, LLC reported holding 758,257 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$87.4M, representing 2.40% of its reported portfolio and ranking #2 among its reported holdings. EMERALD ADVISERS, LLC has disclosed CORT holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)758.26K sh
Reported value held$87.37M
Portfolio Weight2.40%
First reportedQ1 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EMERALD ADVISERS, LLC's CORT position evolved

EMERALD ADVISERS, LLC first disclosed a stake in CORT in Q1 2025 at 62,182 shares (US$7.1M). The position peaked in Q3 2026 at 758,257 shares, worth US$87.4M. Across 7 filings, EMERALD ADVISERS, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 758,257 shares valued at US$87.4M — an increase of 9,932 shares quarter over quarter.. Notable position changes include a 289% increase in Q2 2025 (shares rose 13% over the following quarter), a 264% increase in Q2 2026 (shares rose 33% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 62.18K $7.10M New
Q2 2025 242.05K $17.77M Add
Q3 2025 232.45K $19.32M Reduce
Q4 2025 232.74K $8.10M Hold
Q1 2026 205.56K $8.29M Reduce
Q2 2026 748.33K $65.07M Add
Q3 2026 758.26K $87.37M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CORT and 13F data

CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$558.9M), Parallel Advisors, LLC (US$449.7M), TANG CAPITAL MANAGEMENT LLC (US$130.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CORT

All CORT fund holders →

FAQ

How long has EMERALD ADVISERS, LLC held CORT?

EMERALD ADVISERS, LLC has disclosed CORT holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is EMERALD ADVISERS, LLC's current position in CORT?

As of Q3 2026, EMERALD ADVISERS, LLC holds 758.26K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $87.37M, representing 2.40% of its reported portfolio and ranking #2.

Has EMERALD ADVISERS, LLC been buying or selling CORT?

In the latest 13F filing (Q3 2026), EMERALD ADVISERS, LLC increased its position in CORT. The position peaked in Q3 2026 at 758.26K shares.

Which other funds hold CORT?

Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.